Japan's H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and Belgium-based ADx NeuroS...
Fujitsu and Salesforce Japan have announced the start of a collaboration to create new digital solutions for the healthc...
Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., (NX Group) has become the first Japanese log...
French firm Saint-Gobain Life Sciences has announced the expansion of its manufacturing facility in Suwa, Japan to ...
Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 8...
Japan-based Shionogi & Co. and the Global Antibiotic Research and Development Partnership (GARDP) have announced the...
Japan's Nippon Express, a group company of Nippon Express Holdings, Inc., launched a logistics service capable of handli...
An estimated 13 million people are living with osteoporosis in Japan. The bone disorder results in painful and disabling...
Japan-based startup LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutic...
Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...
ViiV Healthcare, the global specialist HIV company majority-owned by GSK with Pfizer and Shionogi as shareholders, has o...
Moderna and Takeda have announced to transfer the marketing authorization in Japan for Moderna’s COVID-1...
Eurofins Scientific, a global scientific leader in bioanalytical testing and clinical diagnostics testing, has announced...
There are certain situations where maintaining distance to reduce the spread of COVID-19 is difficult, such as when a do...
EA Pharma and its parent company Eisai, and Mochida Pharmaceutical have announced today that “MOVICOL HD&rdqu...
Tohoku University- Tohoku Medical Megabank Organization, Daiichi Sankyo Company, Takeda Pharmaceutical Company, and MICI...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Japan-based Global Health Innovative Technolog...
Japanese firm Kyowa Kirin has decided to build a new active pharmaceutical ingredient (API) manufacturing building (HB7 ...
